UBS Group’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.8K | Sell |
25,590
-370,546
| -94% | -$519K | ﹤0.01% | 6739 |
|
|
2025
Q1 | $638K | Buy |
396,136
+307,320
| +346% | +$495K | ﹤0.01% | 4519 |
|
|
2024
Q4 | $112K | Buy |
88,816
+51,837
| +140% | +$65.3K | ﹤0.01% | 5585 |
|
|
2024
Q3 | $69.5K | Buy |
36,979
+14,205
| +62% | +$26.7K | ﹤0.01% | 5407 |
|
|
2024
Q2 | $169K | Sell |
22,774
-4,942
| -18% | -$36.6K | ﹤0.01% | 4666 |
|
|
2024
Q1 | $217K | Sell |
27,716
-2,041
| -7% | -$16K | ﹤0.01% | 4663 |
|
|
2023
Q4 | $151K | Buy |
29,757
+17,594
| +145% | +$89.4K | ﹤0.01% | 4756 |
|
|
2023
Q3 | $72K | Buy |
+12,163
| New | +$72K | ﹤0.01% | 4940 |
|
|
2023
Q2 | – | Sell |
-2,704
| Closed | -$25.6K | – | 7791 |
|
|
2023
Q1 | $25.6K | Sell |
2,704
-531
| -16% | -$5.02K | ﹤0.01% | 5815 |
|
|
2022
Q4 | $34.5K | Buy |
3,235
+1,399
| +76% | +$14.9K | ﹤0.01% | 5937 |
|
|
2022
Q3 | $13K | Buy |
1,836
+1,800
| +5,000% | +$12.7K | ﹤0.01% | 6905 |
|
|
2022
Q2 | $0 | Buy |
+36
| New | – | ﹤0.01% | 9230 |
|
|
2022
Q1 | – | Sell |
-50
| Closed | – | – | 9139 |
|
|
2021
Q4 | $0 | Sell |
50
-100
| -67% | – | ﹤0.01% | 9096 |
|
|
2021
Q3 | $1K | Sell |
150
-2,693
| -95% | -$18K | ﹤0.01% | 7979 |
|
|
2021
Q2 | $22K | Buy |
2,843
+2,693
| +1,795% | +$20.8K | ﹤0.01% | 6133 |
|
|
2021
Q1 | $1K | Buy |
+150
| New | +$1K | ﹤0.01% | 7703 |
|
|
2020
Q3 | – | Sell |
-2,437
| Closed | -$26K | – | 7063 |
|
|
2020
Q2 | $26K | Sell |
2,437
-1,924
| -44% | -$20.5K | ﹤0.01% | 5522 |
|
|
2020
Q1 | $25K | Sell |
4,361
-1,472
| -25% | -$8.44K | ﹤0.01% | 5443 |
|
|
2019
Q4 | $38K | Buy |
5,833
+3,178
| +120% | +$20.7K | ﹤0.01% | 5455 |
|
|
2019
Q3 | $18K | Sell |
2,655
-689
| -21% | -$4.67K | ﹤0.01% | 5828 |
|
|
2019
Q2 | $25K | Buy |
3,344
+3,063
| +1,090% | +$22.9K | ﹤0.01% | 5588 |
|
|
2019
Q1 | $4K | Sell |
281
-1,070
| -79% | -$15.2K | ﹤0.01% | 6408 |
|
|
2018
Q4 | $16K | Buy |
+1,351
| New | +$16K | ﹤0.01% | 6011 |
|
|
2018
Q2 | – | Sell |
-114
| Closed | -$1K | – | 7009 |
|
|
2018
Q1 | $1K | Sell |
114
-5,289
| -98% | -$46.4K | ﹤0.01% | 6722 |
|
|
2017
Q4 | $108K | Buy |
+5,403
| New | +$108K | ﹤0.01% | 4367 |
|
|
2017
Q2 | – | Sell |
-435
| Closed | -$20K | – | 6674 |
|
|
2017
Q1 | $20K | Buy |
435
+308
| +243% | +$14.2K | ﹤0.01% | 5219 |
|
|
2016
Q4 | $3K | Buy |
+127
| New | +$3K | ﹤0.01% | 6411 |
|
|
2016
Q3 | – | Sell |
-172
| Closed | -$9K | – | 6685 |
|
|
2016
Q2 | $9K | Buy |
+172
| New | +$9K | ﹤0.01% | 5935 |
|
|
2015
Q3 | – | Sell |
-13
| Closed | -$1K | – | 6837 |
|
|
2015
Q2 | $1K | Sell |
13
-32
| -71% | -$2.46K | ﹤0.01% | 6641 |
|
|
2015
Q1 | $3K | Sell |
45
-2
| -4% | -$133 | ﹤0.01% | 6336 |
|
|
2014
Q4 | $8K | Buy |
+47
| New | +$8K | ﹤0.01% | 6109 |
|